Stay updated on ELVN-001 for CML Treatment Clinical Trial
Sign up to get notified when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.

Latest updates to the ELVN-001 for CML Treatment Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows a new revision tag 'Revision: v3.4.2' and older notices about government funding and NIH operations have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoChange DetectedNotice about a lapse in government funding and NIH operations; version updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check25 days agoChange DetectedUI and metadata updates include a new 'Show glossary' toggle and the display of Last Update Submitted that Met QC Criteria and Last Update Posted, as well as the addition of 'No FEAR Act Data' and a revision note of v3.4.0. The previous items 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', and 'No FEAR Act data' have been removed or adjusted in the transition to v3.4.0.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page shows a new revision (v3.3.4) and a Withdrawn status; recruitment contacts and site recruiting indicators were removed.SummaryDifference0.3%

- Check60 days agoChange DetectedA consolidated 'Locations' section now includes New York, Oregon, Texas, Ontario, and Jeollabuk-do, and the separate location subsections for these sites were removed. The page revision tag shows Revision: v3.3.3.SummaryDifference0.4%

- Check89 days agoChange DetectedAdded Fadi Haddad, MD as a study contact and removed Koji Sasaki, MD. The page now shows Last Update Posted (Estimated) and revision v3.3.2.SummaryDifference0.2%

Stay in the know with updates to ELVN-001 for CML Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.